| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |